InvestorsObserver
×
News Home

Is LifeMD Inc (LFMD) a Leader in the Pharmaceutical Retailers Industry?

Monday, October 23, 2023 01:38 PM | InvestorsObserver Analysts

Mentioned in this article

Is LifeMD Inc (LFMD) a Leader in the Pharmaceutical Retailers Industry?

A rating of 100 puts LifeMD Inc (LFMD) near the top of the Pharmaceutical Retailers industry according to InvestorsObserver. LifeMD Inc's score of 100 means it scores higher than 100% of stocks in the industry. LifeMD Inc also received an overall rating of 66, putting it above 66% of all stocks. Pharmaceutical Retailers is ranked 119 out of the 148 industries.

Overall Score - 66
LFMD has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on LFMD!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With LifeMD Inc Stock Today?

LifeMD Inc (LFMD) stock is trading at $6.72 as of 1:25 PM on Monday, Oct 23, a rise of $0.31, or 4.79% from the previous closing price of $6.41. The stock has traded between $5.97 and $6.84 so far today. Volume today is below average. So far 390,282 shares have traded compared to average volume of 639,094 shares. Click Here to get the full Stock Report for LifeMD Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App